BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.38
+0.08 (0.86%)
At close: Aug 7, 2026, 4:00 PM EDT
9.42
+0.04 (0.43%)
After-hours: Aug 7, 2026, 7:51 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +241.15% | Aug 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $20 | Buy | Maintains | $20 | +113.22% | Aug 6, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $14 → $13 | Buy | Reiterates | $14 → $13 | +38.59% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +219.83% | Aug 6, 2026 |
| Needham | Needham | Buy Maintains $16 | Buy | Maintains | $16 | +70.58% | Aug 5, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +59.91% | Jul 15, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Initiates $12 | Hold | Initiates | $12 | +27.93% | Jul 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +209.17% | Jun 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.